As of 2025-11-16, the Relative Valuation of Treace Medical Concepts Inc (TMCI) is (14.27) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.03 USD, the upside of Treace Medical Concepts Inc based on Relative Valuation is -571.1%.
The range of the Relative Valuation is (13.40) - (13.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.4x - 46.0x | 41.1x |
| Forward P/E multiples | 32.1x - 36.6x | 34.3x |
| Fair Price | (13.40) - (13.84) | (14.27) |
| Upside | -542.4% - -556.9% | -571.1% |
| Date | P/E |
| 2025-11-13 | -8.29 |
| 2025-11-12 | -8.78 |
| 2025-11-11 | -8.87 |
| 2025-11-10 | -9.40 |
| 2025-11-07 | -11.79 |
| 2025-11-06 | -16.45 |
| 2025-11-05 | -16.51 |
| 2025-11-04 | -17.22 |
| 2025-11-03 | -17.40 |
| 2025-10-31 | -16.88 |
| 2025-10-30 | -16.77 |
| 2025-10-29 | -17.30 |
| 2025-10-28 | -18.06 |
| 2025-10-27 | -18.09 |
| 2025-10-24 | -18.14 |
| 2025-10-23 | -17.93 |
| 2025-10-22 | -18.12 |
| 2025-10-21 | -18.36 |
| 2025-10-20 | -17.96 |
| 2025-10-17 | -17.01 |
| 2025-10-16 | -16.85 |
| 2025-10-15 | -16.16 |
| 2025-10-14 | -16.37 |
| 2025-10-13 | -15.85 |
| 2025-10-10 | -15.53 |
| 2025-10-09 | -15.93 |
| 2025-10-08 | -16.27 |
| 2025-10-07 | -15.85 |
| 2025-10-06 | -16.64 |
| 2025-10-03 | -16.80 |
| 2025-10-02 | -16.53 |
| 2025-10-01 | -16.69 |
| 2025-09-30 | -17.72 |
| 2025-09-29 | -17.75 |
| 2025-09-26 | -17.59 |
| 2025-09-25 | -17.64 |
| 2025-09-24 | -17.91 |
| 2025-09-23 | -17.96 |
| 2025-09-22 | -18.22 |
| 2025-09-19 | -18.20 |
| 2025-09-18 | -18.99 |
| 2025-09-17 | -18.59 |
| 2025-09-16 | -18.67 |
| 2025-09-15 | -19.07 |
| 2025-09-12 | -19.07 |
| 2025-09-11 | -19.65 |
| 2025-09-10 | -18.49 |
| 2025-09-09 | -19.54 |
| 2025-09-08 | -18.78 |
| 2025-09-05 | -18.94 |